ArticleNature medicine2022
An early warning system for emerging SARS-CoV-2 variants.
Abstract read
In one paragraph
Article in Nature medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.
0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed.
- Nipah virus and the lessons of COVID-19: are we prepared for the next pandemic threat?Infectious medicine · 2026Review
- Tracking the shifting landscape of SARS-CoV-2 variants in Lebanon among healthcare workers and hospitalized patients.Microbiology spectrum · 2026Article
- A phase 1 clinical trial of a multi-antigen SARS-CoV DNA vaccine as a booster after dose three spike-based mRNA vaccinations.Molecular therapy. Advances · 2026Article
- Risk of stroke following SARS-CoV-2 infection in a nationwide self-controlled case series study in qatar.Scientific reports · 2026Observational
- Optimizing global genomic surveillance for early detection of emerging SARS-CoV-2 variants.Nature communications · 2026Article
- A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023.Communications medicine · 2025Review
- Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in Qatar.Scientific reports · 2025Article
- Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities.BMJ open respiratory research · 2025Article
- Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar.Open forum infectious diseases · 2025Article
- Article
- VirusWarn: A mutation-based early warning system to prioritize concerning SARS-CoV-2 and influenza virus variants from sequencing data.Computational and structural biotechnology journal · 2025Article
- Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq.Pathogens (Basel, Switzerland) · 2024Article
- Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders.bioRxiv : the preprint server for biology · 2024Article
- Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders.Briefings in bioinformatics · 2024Article
- Report of SARS-CoV-2 JN.1 variant in Morocco.Microbiology resource announcements · 2024Article
- Surveillance strategies for the detection of new pathogen variants across epidemiological contexts.PLoS computational biology · 2024Article
- An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution.Nature medicine · 2024Article
- Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality.Cell death and differentiation · 2024Article
- SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs.Cell chemical biology · 2024Review
- Data-driven recombination detection in viral genomes.Nature communications · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
61 authors.
Lorenzo SubissiWorld Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-5147-575X
Anne von GottbergNational Institute for Communicable Diseases, Johannesburg, South Africa.ORCID http://orcid.org/0000-0002-0243-7455
Lipi ThukralCSIR Institute of Genomics and Integrative Biology, Delhi, India.
Nathalie WorpErasmus Medical Centre, Rotterdam, the Netherlands.
Bas B Oude MunninkErasmus Medical Centre, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0002-9394-1189
Surabhi RathoreCSIR Institute of Genomics and Integrative Biology, Delhi, India.
Laith J Abu-RaddadWeill Cornell Medicine - Qatar of Cornell University, Doha, Qatar.ORCID http://orcid.org/0000-0003-0790-0506
Ximena AguileraEpidemiology and Health Policy Centre, Universidad del Desarollo, Santiago, Chile.ORCID http://orcid.org/0000-0002-8153-6733
Erik AlmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Brett N ArcherWorld Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-4144-1094
Homa Attar CohenWorld Health Organization, Geneva, Switzerland.
Amal BarakatWorld Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Wendy S BarclayImperial College London, London, UK.ORCID http://orcid.org/0000-0002-3948-0895
Jinal N BhimanNational Institute for Communicable Diseases, Johannesburg, South Africa.ORCID http://orcid.org/0000-0001-6354-4003
Leon CalyVictorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia.
Meera ChandUK Health Security Agency, London, UK.
Mark ChenNational Centre for Infectious Diseases, Singapore, Singapore.
Ann CullinaneWorld Organisation for Animal Health, Paris, France.
Tulio de OliveiraCentre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa.
Christian DrostenCharité Medical Center, Berlin, Germany.ORCID http://orcid.org/0000-0001-7923-0519
Julian DruceEpidemiology and Health Policy Centre, Universidad del Desarollo, Santiago, Chile.
Paul EfflerUniversity of Western Australia, Perth, Western Australia, Australia.
Ihab El MasryFood and Agriculture Organization, Rome, Italy.
Adama FayeInstitut de Santé et Développement, Université Cheikh Anta Diop, Dakar, Senegal.
Simani GaseitsiweBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
Elodie GhedinNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-1515-725X
Rebecca GrantWorld Health Organization, Geneva, Switzerland.
Bart L HaagmansErasmus Medical Centre, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0001-6221-2015
Belinda L HerringWorld Health Organization Regional Office for Africa, Brazzaville, Republic of Congo.
Shilpa S IyerWorld Health Organization Regional Office for Western Pacific, Manila, The Philippines.
Zyleen KassamaliWorld Health Organization, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-0668-7099
Manish KakkarWorld Health Organization Regional Office for South-East Asia, New Delhi, India.ORCID http://orcid.org/0000-0002-3254-0496
Rebecca J KondorUnited States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Juliana A LeiteWorld Health Organization Regional Office for the Americas, Washington, DC, USA.ORCID http://orcid.org/0000-0002-8620-114X
Yee-Sin LeoNational Centre for Infectious Diseases, Singapore, Singapore.ORCID http://orcid.org/0000-0003-4978-5825
Gabriel M LeungSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, The People's Republic of China.
Marco MarklewitzWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-1828-8770
Sikhulile MoyoBotswana Harvard AIDS Institute Partnership, Gaborone, Botswana.ORCID http://orcid.org/0000-0003-3821-4592
Jairo Mendez-RicoWorld Health Organization Regional Office for the Americas, Washington, DC, USA.
Nada M MelhemAmerican University of Beirut, Beirut, Lebanon.ORCID http://orcid.org/0000-0002-5423-4908
Vincent MunsterNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.ORCID http://orcid.org/0000-0002-2288-3196
Karen NahapetyanWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Djin-Ye OhRobert Koch Institute, Berlin, Germany.
Boris I PavlinWorld Health Organization, Geneva, Switzerland.
Thomas P PeacockImperial College London, London, UK.ORCID http://orcid.org/0000-0001-7077-2928
Malik PeirisSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, The People's Republic of China.ORCID http://orcid.org/0000-0001-8217-5995
Zhibin PengChinese Center for Disease Control and Prevention, Beijing, The People's Republic of China.
Leo L M PoonSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, The People's Republic of China.ORCID http://orcid.org/0000-0002-9101-7953
Andrew RambautUniversity of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0003-4337-3707
Jilian SacksWorld Health Organization, Geneva, Switzerland.
Yinzhong ShenShanghai Public Health Clinical Center, Fudan University, Shanghai, The People's Republic of China.
Marilda M SiqueiraOswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Sofonias K TessemaAfrica Centers for Disease Control and Prevention, Addis Ababa, Ethiopia.
Erik M VolzImperial College London, London, UK.ORCID http://orcid.org/0000-0001-6268-8937
Volker ThielMultidisciplinary Center for Infectious Diseases, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0002-5783-0887
Sylvie van der WerfInstitut Pasteur, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0002-1148-4456
Sylvie BriandWorld Health Organization, Geneva, Switzerland.
Mark D PerkinsWorld Health Organization, Geneva, Switzerland.
Maria D Van KerkhoveWorld Health Organization, Geneva, Switzerland. vankerkhovem@who.int.ORCID http://orcid.org/0000-0002-6135-0018
Marion P G KoopmansErasmus Medical Centre, Rotterdam, the Netherlands.ORCID http://orcid.org/0000-0002-5204-2312
Anurag AgrawalTrivedi School of Biosciences, Ashoka University, Sonipat, India.
Funding
Virus Ecology Unit - COVID-19 responseZIAAI001289 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MUNSTER, VINCENT · 2020 to 2025
$4.7MDetermining factors of transmission and evolution of SARS-CoV-2 in populations at risk ZIAAI001324 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GHEDIN, ELODIE · 2020 to 2025
$2.7MIntramural NIH HHS ZIA AI001324Medical Research Council MR/R015600/1Wellcome Trust 206298/Z/17/ZWorld Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19SARS-CoV-2Humans
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.